Abstract
Organized jointly by the European Confederation of Medical Mycology (ECMM) and the Infectious Diseases Group of the European Organization for Research and Treatment of Cancer (IDGEORTC), Trends in Medical Mycology (TIMM) has be-come the essential global forum to discuss the most important advances and research find-ings in mycology from basic science to clinical and laboratory research. TIMM-7 was the seventh of this series of biennial international meetings for physicians and scientists with interests in medical mycology. Delegates heard expert presentations on a range of topics, but antifungal drug resistance was a key concern for the meeting in light of the threat posed to the health and survival of seriously ill, immunocompromized patients.
Keywords: Invasive fungal infections, resistance, candida, aspergillus.
Graphical Abstract
Anti-Infective Agents
Title:Facing the threat of Antifungal Resistance: Report from the 7th Trends in Medical Mycology (TIMM-7) 9-12 October 2015, Lisbon, Portugal
Volume: 14 Issue: 2
Author(s): Sue Lyon
Affiliation:
Keywords: Invasive fungal infections, resistance, candida, aspergillus.
Abstract: Organized jointly by the European Confederation of Medical Mycology (ECMM) and the Infectious Diseases Group of the European Organization for Research and Treatment of Cancer (IDGEORTC), Trends in Medical Mycology (TIMM) has be-come the essential global forum to discuss the most important advances and research find-ings in mycology from basic science to clinical and laboratory research. TIMM-7 was the seventh of this series of biennial international meetings for physicians and scientists with interests in medical mycology. Delegates heard expert presentations on a range of topics, but antifungal drug resistance was a key concern for the meeting in light of the threat posed to the health and survival of seriously ill, immunocompromized patients.
Export Options
About this article
Cite this article as:
Lyon Sue, Facing the threat of Antifungal Resistance: Report from the 7th Trends in Medical Mycology (TIMM-7) 9-12 October 2015, Lisbon, Portugal, Anti-Infective Agents 2016; 14 (2) . https://dx.doi.org/10.2174/2211352514666160819162110
DOI https://dx.doi.org/10.2174/2211352514666160819162110 |
Print ISSN 2211-3525 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-3533 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Gynaecological Cancer Diagnostics: 99mTc-Cisplatin Complex as a Future Approach for Early, Prompt and Efficient Diagnosis of Gynaecological Cancer
Current Medical Imaging The Effects of Psychological Stress on Depression
Current Neuropharmacology Can Targeting the Incretin Pathway Dampen RAGE-Mediated Events in Diabetic Nephropathy?
Current Drug Targets Hemostatic Factors and the Metabolic Syndrome
Current Vascular Pharmacology Does Calprotectin Represent a Regulatory Factor in Host Defense or a Drug Target in Inflammatory Disease?
Endocrine, Metabolic & Immune Disorders - Drug Targets New Organ-Specific Pharmacological Strategies Interfering With Signaling Pathways In Inflammatory Disorders/Autoimmune Disorders
Current Signal Transduction Therapy Extracellular Vesicles as Innovative Tools for Assessing Adverse Effects of Immunosuppressant Drugs
Current Medicinal Chemistry Synthesis and Anti-thyroid Cancer Effect of Iodo-chrysin Derivatives
Medicinal Chemistry Treatment of MDR1 Mutant Dogs with Macrocyclic Lactones
Current Pharmaceutical Biotechnology Endoplasmic Stress Inhibitors for Homocysteine Induced Cardiovascular Disease
Current Pharmaceutical Design Ghrelin and the Brain-gut Axis as a Pharmacological Target for Appetite Control
Current Pharmaceutical Design Risk Factors for Upper GI Damage in Low-Dose Aspirin Users and the Interaction Between <i>H. pylori</i> Infection and Low-Dose Aspirin Use
Current Pharmaceutical Design Chemistry and Health Effects of Bioactive Compounds in Selected Culinary Aromatic Herbs
Current Nutrition & Food Science Abundance and Diversity of GI Microbiota Rather than IgG<sub>4</sub> Levels Correlate with Abdominal Inconvenience and Gut Permeability in Consumers Claiming Food Intolerances
Endocrine, Metabolic & Immune Disorders - Drug Targets Bioactive Peptides from Marine Sources as Potential Anti-Inflammatory Therapeutics
Current Protein & Peptide Science Circulating Advanced Oxidation Protein Products as Oxidative Stress Biomarkers and Progression Mediators in Pathological Conditions Related to Inflammation and Immune Dysregulation
Current Medicinal Chemistry Interaction of Drug or Food with Drug Transporters in Intestine and Liver
Current Drug Metabolism Pyrazolo-Triazolo-Pyrimidine Derivatives as Adenosine Receptor Antagonists: A Possible Template for Adenosine Receptor Subtypes?
Current Pharmaceutical Design Colon Targeted Rifaximin Nanosuspension for the Treatment of Inflammatory Bowel Disease (IBD)
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Metabolomics and the Diagnosis of Human Diseases -A Guide to the Markers and Pathophysiological Pathways Affected
Current Medicinal Chemistry